Arca
Skip to content

Ceramax Skin Barrier Cream

Dressing, Wound, Drug. 510(k) K152055, from Oculus Innovative Sciences (Petaluma, CA). Product code FRO, class U.

As of Nov 17, 2026, K152055 is an FDA 510(k) held by Oculus Innovative Sciences, substantially equivalent on Nov 23, 2015 after 122 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Nov 23, 2015
  • Review time: 122 days
  • Recalls: 1

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

INDICATION FOR USE Under the supervision of a health care professional, Ceramax is intended to be used as a topical skin care preparation to relieve and to manage the burning, and itching associated with various dermatoses including atopic dermatitis, irritant contact dermatitis, radiation dermatitis and other dry skin conditions, by maintaining a moist wound and skin environment.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Recalls

Recalls FDA ties to K152055, newest first; each opens FDA's recall record
StartedReasonStatus
Nov 21, 2016Z-0763-2017Firm became aware that professional samples of Ceramax are not meeting stability standards set for the product.Terminated

Other FRO Clearances

The newest 510(k)s for the same product code; their median review was 269 days; see every FRO device

Record

Type
Traditional
Received
Jul 24, 2015
Review panel
Unknown

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.